The efficacy and safety of dual-target rTMS over dorsolateral prefrontal cortex (DLPFC) and cerebellum in the treatment of negative symptoms in first-episode schizophrenia: Protocol for a multicenter, randomized, double-blind, sham-controlled study - Wang J; Wei Y; Hu Q; Tang Y; Zhu H; Wang J (Schizophrenia Research: Cognition, 2025)
FEMU ID: 57655; EMF-Portal URL: https://www.emf-portal.org/en/article/57655